Author: Chen, Fangfang; Liu, Zhihong; Jiang, Fan
Title: Prospects of Neutralizing Nanobodies Against SARS-CoV-2 Cord-id: zpvkxw5o Document date: 2021_5_28
ID: zpvkxw5o
Snippet: Since December 2019, the SARS-CoV-2 has erupted on a large scale worldwide and spread rapidly. Passive immunization of antibody-related molecules provides opportunities for prevention and treatment of high-risk patients and children. Nanobodies (Nbs) have many strong physical and chemical properties. They can be atomized, administered by inhalation, and can be directly applied to the infected site, with fast onset, high local drug concentration/high bioavailability, and high patient compliance (
Document: Since December 2019, the SARS-CoV-2 has erupted on a large scale worldwide and spread rapidly. Passive immunization of antibody-related molecules provides opportunities for prevention and treatment of high-risk patients and children. Nanobodies (Nbs) have many strong physical and chemical properties. They can be atomized, administered by inhalation, and can be directly applied to the infected site, with fast onset, high local drug concentration/high bioavailability, and high patient compliance (no needles). It has very attractive potential in the treatment of respiratory viruses. Rapid and low-cost development of Nbs targeting SARS-CoV-2 can quickly be achieved. Nbs against SARS-CoV-2 mutant strains also can be utilized quickly to prevent the virus from escaping. It provides important technical supports for the treatment of the SARS-CoV-2 and has the potential to become an essential medicine in the toolbox against the SARS-CoV-2.
Search related documents:
Co phrase search for related documents- long term storage and low production cost: 1
- low efficiency and lung disease: 1
- low production cost and lung infection: 1, 2
- low quality and lung damage: 1
- low quality and lung disease: 1, 2, 3, 4
- low quality and lung infection: 1, 2
- lung damage and macrophage monocyte: 1, 2, 3, 4, 5
- lung disease and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8
- lung infection and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date